Citations

Clear

195 citation(s) found for "Moran, Steven".

Abstract QS25: Limb-preserving Autologous Reconstruction In Patients With Soft-tissue Malignant Neoplasms: An Analysis Of 468 Cases From 2005 - 2017 ACS-NSQIP National Database
Bustos, Samyd S. , Galvez, Gabriel F. Martinez, Forte, Antonio J. , Carlsen, Brian T. , Moran, Steven L. , Manrique, Oscar J. , Forte, Antonio Jorge , Bustos, S S , Yan, María , Kuruoglu, Doga

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | May 12, 2020 | Volume: 8 | Issue: 4S | Pages: 153-153

10.1097/01.gox.0000667956.37150.bc Get It

Adolescent Kienböck's Disease: A Comparison between Lunate Offloading and Revascularization Procedures
Khouri, Joseph S., Moran, Steven L. , Gillis, Joshua A.

Mayo Clinic

Journal of Wrist Surgery | February 20, 2020 | Volume: 09 | Issue: 03 | Pages: 197-202

10.1055/s-0040-1701511 | PMID 32509422 Get It

Abstract Objective To evaluate the outcomes and complication rate of surgical management in adolescent patients with Kienböck's disease and compare lunate offloading and revascularization procedures. Methods We performed a retrospective chart review to evaluate adolescent patients with Kienböck's disease between 1990 and 2016 who were surgically managed. Charts were reviewed for demographic information, presence of trauma, range of motion, grip strength, and radiographic parameters pre- and postoperative. Results We assessed 21 wrists in 20 patients. All had failed conservative management and required surgery. Seven patients underwent lunate offloading procedures, most commonly radial-shortening osteotomy, whereas 13 patients had an attempt at revascularization. All patients had either minimal or no pain at a clinical mean clinical follow-up of 63.4 months. Postoperatively, grip strength and radial deviation improved, with no difference between the two groups. Those that underwent joint offloading procedures had less ulnar variance. Eight of 11 patients with a postoperative MRI (magnetic resonance imaging) had evidence of lunate revascularization after a revascularization procedure. Conclusion Surgical management of Kienböck's disease in adolescent patients can yield satisfactory outcomes in those that fail conservative management. Level of Evidence/Type of study This is a Level IV, therapeutic study.
Frequency, Pattern, and Treatment of Hand Fractures in Children and Adolescents: A 27-Year Review of 4356 Pediatric Hand Fractures
Kreutz‐Rodrigues, Lucas , Moran, Steven L. , Carlsen, Brian T. , Bakri, Karim , Bakri, Karim , Gibreel, Waleed

Mayo Clinic

HAND | February 10, 2020 | Volume: 17 | Issue: 1 | Pages: 92-97

10.1177/1558944719900565 | PMID 32036680 Get It

Background: The frequency, pattern, and treatment of pediatric hand fractures are rarely reported. We sought to review our institution’s experience in the management of pediatric hand fractures. Methods: A retrospective review of children and adolescents (younger than 18 years) treated for hand fractures between January 1990 and June 2017 was preformed. Fractures were categorized into metacarpal, proximal/middle phalanx, distal phalanx, or intra-articular metacarpophalangeal (MCP)/proximal interphalangeal (PIP)/distal interphalangeal (DIP) fractures. Patients were categorized into 3 age groups (0-5, 6-11, and 12-17 years). Results: A total of 4356 patients were treated for hand fractures at a mean ± SD age of 12.2 ± 3.5 years. Most fractures occurred in patients aged 12 to 17 years (n = 2775, 64%), followed by patients aged 6 to 11 years (n = 1347, 31%). Only 234 (5%) fractures occurred in children younger than 5 years. Most fractures occurred in the proximal/middle phalanx (48%), followed by metacarpal (33%), distal phalangeal (12%), and intra-articular MCP/PIP/DIP joints (7%). Proximal/middle phalangeal fractures were the most common in all age groups. About 58% of intra-articular MCP/PIP/DIP fractures in patients aged between 0 and 5 years required open reduction ± fixation, and the remaining 42% fractures were amenable to closed reduction. In patients older than 5 years, about 70% of these fractures were amenable to closed reduction. All age groups included, most metacarpal (93%), proximal/middle phalangeal (92%), and distal phalangeal (86%) fractures were amenable to closed reduction alone. Conclusions: The frequency, pattern, and treatment of hand fractures vary among different age groups. Understanding the pattern of these fractures helps making the right diagnosis and guides choosing the appropriate treatment.
Muscle Flap Transposition for the Management of Intrathoracic Fistulas
Handel, Amelia Van, Akhavan, Arya , Huang, Tony Chieh‐Ting , Allen, Mark A., Shen, K. Robert , Sharaf, Basel , Moran, Steven L. , Van Handel, Amelia, Akhavan, Arya A, Rajesh, Aashish , Sharaf, Basel A , Asaad, Malke

Mayo Clinic

Plastic & Reconstructive Surgery | January 13, 2020 | Volume: 145 | Issue: 4 | Pages: 829e-838e

10.1097/prs.0000000000006670 | PMID 32221235 Get It

Background: Intrathoracic fistulas pose unique challenges for thoracic and reconstructive surgeons. To decrease the incidence of fistula recurrence, pedicled flaps have been suggested to buttress the repair site. The authors aimed to report their experience with muscle flap transposition for the management of intrathoracic fistulas. Methods: A retrospective review of all patients who underwent intrathoracic muscle flap transposition for the management of intrathoracic fistulas from 1990 to 2010 was conducted. Patient demographics, surgical characteristics, and complication rates were abstracted and analyzed. Results: A total of 198 patients were identified. Bronchopleural fistula was present in 156 of the patients (79 percent), and 48 had esophageal fistula (24 percent). A total of 238 flaps were used, constituting an average of 1.2 flaps per patient. After the initial fistula repair, bronchopleural fistula complicated the course of 34 patients (17 percent), and esophageal fistula occurred in 13 patients (7 percent). Partial flap loss was identified in 11 flaps (6 percent), and total flap loss occurred in four flaps (2 percent). Median follow-up was 27 months. At the last follow-up, 182 of the patients (92 percent) had no evidence of fistula, 175 (89 percent) achieved successful chest closure, and 164 (83 percent) had successful treatment. Preoperative radiation therapy and American Society of Anesthesiologists score of 4 or greater were identified as risk factors for unsuccessful treatment. Conclusions: Intrathoracic fistulas remain a source of major morbidity and mortality. Reinforcement of the fistula closure with vascularized muscle flaps is a viable option for preventing dehiscence of the repair site and can be potentially life-saving. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
Characterization of a purified exosome product and its effects on canine flexor tenocyte biology
Qi, Jun , Liu, Qian , Reisdorf, Ramona L., Boroumand, Soulmaz, Behfar, Atta , Moran, Steven L. , Amadio, Peter C. , Gingery, Anne , Zhao, Chunfeng , Liu, Qian , Behfar, Atta , Gingery, Anne

Mayo Clinic

Journal of Orthopaedic Research | January 13, 2020 | Volume: 38 | Issue: 8 | Pages: 1845-1855

10.1002/jor.24587 | PMID 31930553 Get It

AbstractFlexor tendon injuries and tendinopathy are very common but remain challenging in clinical treatment. Exosomes‐based cell‐free therapy appears to be a promising strategy for tendon healing, while limited studies have evaluated its impacts on tenocyte biology. The objective of this study was to characterize a novel purified exosome product (PEP) derived from plasma, as well as to explore its cellular effects on canine tenocyte biology. The transmission electron microscope revealed that exosomes of PEP present cup‐shaped structures with the diameters ranged from 80 to 141 nm, and the NanoSight report presented that their size mainly concentrated around 100 nm. The enzyme‐linked immunosorbent assay kits analysis showed that PEP was positive for CD63 and AChE expression, and the cellular uptake of exosomes internalized into tenocyte cytoplasm was observed. The cell growth assays displayed that tenocyte proliferation ability was enhanced by PEP solution in a dose‐dependent manner. Tenogenic phenotype was preserved as is evident by that tendon‐related genes expression (SCX, COL1A, COL3A1, TNMD, DCN, and MKX) were expressed insistently in a high level, while tenocytes were treated with 5% PEP solution. Furthermore, migration capability was maintained and total collagen deposition was increased. More interesting, dexamethasone‐induced cellular apoptosis was attenuated during the incubation of tenocytes with a 5% PEP solution. These findings will provide the basic understandings about the PEP, and support the potential use of this biological strategy for tendon healing.
Extremity free fillet flap for reconstruction of massive oncologic resection—Surgical technique and outcomes
Kreutz‐Rodrigues, Lucas , Mohan, Anita T. , Moran, Steven L. , Carlsen, Brian T. , Mardini, Samir , Houdek, Matthew T. , Rose, Peter S. , Bakri, Karim , Houdek, Matthew T

Mayo Clinic

Journal of Surgical Oncology | December 18, 2019 | Volume: 121 | Issue: 3 | Pages: 465-473

10.1002/jso.25795 | PMID 31853992 Get It

Abstract Background and Objectives The purpose of this study is to present our experience using free fillet flaps to reconstruct massive oncologic defects of the upper and lower extremity. Methods A retrospective chart review was performed to include patients who underwent oncologic resection followed by reconstruction using free fillet flaps from July 2001 to October 2018. Patient demographics, clinical and surgical characteristics, and postoperative complications were reviewed. Results In total, 12 patients were identified and included in this study. Mean age was 48.9 years old. Five patients had extended forequarter amputations and seven patients had external hemipelvectomies, all for locally advanced tumors. Mean tumor size was 15 ± SD 6.4 cm, and negative tumor margins were achieved in all the patients. Mean flap size was 1028 ± SD 869 cm 2 . The mean follow‐up was 13 months. There were no partial or total flap losses in the postoperative period. Two patients had flap‐related postoperative complications, including flap bleeding and wound dehiscence. Median survival was 18 months. Conclusion The free fillet flap is a safe, reliable, and valuable approach for reconstructing oncological defects. It offers the advantage of avoiding donor site morbidity, while providing extensive soft‐tissue coverage as a one‐step solution for massive oncologic defects.
Early Outcomes of Scapholunate Injuries With Concomitant Distal Radius Fractures
Duethman, Nicholas C., Aibinder, William R. , Robinson, Nathaniel L. , Moran, Steven L. , Kakar, Sanjeev , Kakar, Sanjeev , Aibinder, William R

Mayo Clinic

HAND | December 9, 2019 | Volume: 16 | Issue: 5 | Pages: 650-656

10.1177/1558944719890037 | PMID 34549615 Get It

Background: There is limited literature regarding the treatment of concomitant scapholunate ligament (SL) injuries in acute distal radius fractures (DRFs). We hypothesized that surgical treatment of SL injuries in adult patients with DRFs leads to improved functional outcomes. Methods: A retrospective review was made of 42 adult patients who underwent surgical treatment of a DRF with a SL injury between 2005 and 2013. In all, 39 of the 42 patients sustained an intra-articular DRF (AO B or C). SL injury was diagnosed by SL diastasis > 3 mm on posteroanterior (PA) radiographs, magnetic resonance imaging, or with wrist arthroscopy. Patients were divided into 3 groups: 23 had a SL repair and were treated within 21 days of injury (acute), 8 underwent SL repair greater than 21 days from injury (subacute/chronic), and 11 did not undergo repair (non-operative). Median overall time to clinical follow-up was 5.1 years. Mayo Wrist Scores (MWS) and Disabilities of the Arm, Shoulder and Hand (DASH) scores were used to evaluate functional outcome. Results: Clinical outcomes measured by the MWS at final follow-up (6 months-12 years) showed no significant differences between the 3 groups. Of patients treated acutely, 17.3% had good to excellent MWS. MWS at 1-year follow-up was 68.4, 70, and 64 in the acute, subacute/chronic, and non-operative groups, respectively. DASH scores were 16.7, 14.3, and 11.8 in the acute, subacute/chronic, and nonoperative groups, respectively, at a mean of 7.8 years. Conclusions: At mid-term follow-up, all 3 treatment groups had similar DASH scores to the general population. There were no statistical functional differences between any of the groups based upon MWS or DASH scores.
Reconstruction of Oncologic Sternectomy Defects: Lessons Learned from 60 Cases at a Single Institution
Banuelos, Joseph, Bite, Uldis, Moran, Steven L. , Bakri, Karim , Pairolero, Peter C., Arnold, Philip G., Sharaf, Basel , Abu-Ghname, Amjed, Blackmon, Shanda H, Shen, Robert, Allen, Mark S. , Abu‐Ghname, Amjed , Blackmon, Shanda , Shen, Robert K. , Sharaf, Basel A

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | July 29, 2019 | Volume: 7 | Issue: 7 | Pages: e2351

10.1097/gox.0000000000002351 | PMID 31942367 Get It

Background: Oncologic sternectomy results in complex defects where preoperative planning is paramount to achieve best reconstructive outcomes. Although pectoralis major muscle flap (PMF) is the workhorse for sternal soft tissue coverage, additional flaps can be required. Our purpose is to evaluate defects in which other flaps beside PMF were required to achieve optimal reconstruction. Methods: A retrospective review of consecutive patients at our institution who underwent reconstruction after sternal tumor resection was performed. Demographics, surgical characteristics, and outcomes were evaluated. Further analysis was performed to identify defect characteristics where additional flaps to PMF were needed to complete reconstruction. Results: In 11 years, 60 consecutive patients were identified. Mean age was 58 (28–81) years old, with a mean follow-up of 40.6 (12–64) months. The majority were primary sternal tumors (67%) and the mean defect size was 148 cm2 (±81). Fourteen (23%) patients presented with postoperative complications, and the 30-day mortality rate was 1.6%. In 19 (32%) cases, additional flaps were required; the most common being the rectus abdominis muscle flaps. Larger thoracic defects (P = 0.011) and resections involving the inferior sternum (P = 0.021) or the skin (P = 0.011) were more likely to require additional flaps. Conclusions: Reconstruction of oncologic sternal defects requires a multidisciplinary team approach. Larger thoracic defects, particularly those that involve the skin and the inferior sternum, are more likely to require additional flaps for optimal reconstruction.
Bilateral Kienböck’s disease in a child with Factor V Leiden thrombophilia: a case report
Huang, Tony Chieh‐Ting , Li, Jialun , Moran, Steven L.

Mayo Clinic

Journal of Hand Surgery (European Volume) | July 26, 2019 | Volume: 44 | Issue: 8 | Pages: 859-861

10.1177/1753193419864815 | PMID 31345086 Get It

Direct muscle neurotization with long acellular nerve allograft: A case report
Tuffaha, Sami , Meaike, Jesse D. , Moran, Steven L. , Tuffaha, Sami H

Mayo Clinic

Microsurgery | July 22, 2019 | Volume: 40 | Issue: 2 | Pages: 258-260

10.1002/micr.30498 | PMID 31328294 Get It

AbstractNerve repair and nerve transfer are the optimal approaches to restore function to denervated muscle. When the distal‐most portion of the nerve entering the muscle is compromised, these are not possible and direct muscle neurotization (DMN) is considered. We describe the first reported case of DMN with acellular nerve allograft. The patient is a 25 year old male who sustained a blast injury to the patient's proximal leg with segmental injury to the deep peroneal nerve resulting in complete foot drop with 0/5 dorsiflexion and toe extension. Given complete obliteration of the distal nerve, we performed direct neurotization of the tibialis anterior muscle with a 7 cm acellular nerve allograft coapted to the proximal stump of the deep peroneal nerve. At 3 years after surgery, the patient regained 5/5 strength with dorsiflexion and toe extension and normal gait. This case supports the use of acellular nerve allografts to restore function to denervated muscle when the distal nerve stump is not available for nerve repair or transfer and there is a desire to avoid the morbidity of autologous nerve graft harvest.